athenahealth, Inc (NASDAQ:ATHN) CEO Jonathan Bush sold 25,000 shares of athenahealth stock in a transaction on Monday, February 5th. The shares were sold at an average price of $145.00, for a total value of $3,625,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Jonathan Bush also recently made the following trade(s):

  • On Thursday, February 1st, Jonathan Bush sold 5,000 shares of athenahealth stock. The shares were sold at an average price of $122.69, for a total value of $613,450.00.
  • On Wednesday, December 26th, Jonathan Bush sold 30,000 shares of athenahealth stock. The shares were sold at an average price of $134.80, for a total value of $4,044,000.00.
  • On Tuesday, December 26th, Jonathan Bush sold 30,000 shares of athenahealth stock. The shares were sold at an average price of $134.80, for a total value of $4,044,000.00.

Shares of athenahealth, Inc (ATHN) traded up $1.32 during trading on Wednesday, hitting $134.08. The company had a trading volume of 502,293 shares, compared to its average volume of 573,919. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.32. athenahealth, Inc has a twelve month low of $95.01 and a twelve month high of $158.66. The firm has a market capitalization of $5,420.00, a PE ratio of 103.14, a PEG ratio of 3.18 and a beta of 1.35.

athenahealth (NASDAQ:ATHN) last announced its quarterly earnings data on Thursday, February 1st. The health services provider reported $1.11 EPS for the quarter, topping analysts’ consensus estimates of $0.63 by $0.48. athenahealth had a return on equity of 9.21% and a net margin of 4.35%. The business had revenue of $329.20 million during the quarter, compared to analysts’ expectations of $319.64 million. During the same period in the previous year, the firm earned $0.62 earnings per share. The firm’s quarterly revenue was up 14.2% compared to the same quarter last year. research analysts predict that athenahealth, Inc will post 2 earnings per share for the current fiscal year.

Institutional investors have recently made changes to their positions in the stock. UBS Asset Management Americas Inc. grew its stake in shares of athenahealth by 33.2% during the second quarter. UBS Asset Management Americas Inc. now owns 30,536 shares of the health services provider’s stock worth $4,292,000 after purchasing an additional 7,605 shares during the period. Rockefeller Financial Services Inc. grew its stake in shares of athenahealth by 293.2% during the third quarter. Rockefeller Financial Services Inc. now owns 9,110 shares of the health services provider’s stock worth $1,133,000 after purchasing an additional 6,793 shares during the period. Toronto Dominion Bank grew its stake in shares of athenahealth by 83.3% during the third quarter. Toronto Dominion Bank now owns 220,000 shares of the health services provider’s stock worth $27,356,000 after purchasing an additional 100,000 shares during the period. Perceptive Advisors LLC acquired a new stake in shares of athenahealth during the third quarter worth $8,705,000. Finally, Fox Run Management L.L.C. acquired a new stake in shares of athenahealth during the third quarter worth $460,000.

Several equities analysts have issued reports on ATHN shares. Piper Jaffray Companies reiterated a “buy” rating and issued a $167.00 price objective on shares of athenahealth in a research report on Tuesday, October 17th. Oppenheimer reiterated a “buy” rating and issued a $184.00 price objective on shares of athenahealth in a research report on Friday, October 20th. SunTrust Banks reiterated a “buy” rating and issued a $156.00 price objective on shares of athenahealth in a research report on Wednesday, October 25th. KeyCorp reiterated a “buy” rating and issued a $152.00 price objective on shares of athenahealth in a research report on Friday, January 12th. Finally, TheStreet downgraded athenahealth from a “b-” rating to a “c+” rating in a research report on Wednesday, October 11th. Three research analysts have rated the stock with a sell rating, sixteen have given a hold rating and eight have assigned a buy rating to the company. athenahealth has a consensus rating of “Hold” and an average price target of $144.96.

TRADEMARK VIOLATION WARNING: “Jonathan Bush Sells 25,000 Shares of athenahealth, Inc (ATHN) Stock” was first published by Daily Political and is owned by of Daily Political. If you are accessing this piece on another site, it was illegally copied and reposted in violation of United States and international trademark and copyright legislation. The original version of this piece can be viewed at https://www.dailypolitical.com/2018/02/07/jonathan-bush-sells-25000-shares-of-athenahealth-inc-athn-stock.html.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Insider Buying and Selling by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.